The long-term objective of the research proposed in this application is to understand in molecular terms how nuclear hormone receptors regulate gene expression within the context of the processes of cell differentiation and growth control. The general strategy employed will be to attempt to describe how a specific trans-acting factor, the vitamin 1,25(OH)2D3 receptor (VDR), influences the proliferation and differentiation of cells of the immune system, while at the same time describing the receptor's structure and function utilizing in vitro and crystallographic approaches. Specifically, the goals are to: 1. Isolate and identify genes that are direct targets of VDR during 1,25(OH)2D3-induced differentiation of the human leukemic cell line U937. A variety of molecular cloning techniques, such as subtraction and expression cloning, will be used to isolate VDR primary response genes. 2. Characterize the mechanism of regulation of such genes by VDR and other potentially interacting factors, and how that regulation results in the cell's commitment to terminally differentiate. The genomic versions of relevant cDNAs will be cloned; how these genes are regulated during 1,25(OH)2D3-induced differentiation will then be investigated. 3. Describe structural and functional aspects of VDR using defined in vitro assays and protein crystallography. VDR will be overexpressed and purified, and its DNA binding and transcriptional regulatory activities examined in detail. Concurrently, an effort to solve the three- dimensional structure of the full-length VDR and smaller derivatives will be initiated in collaboration with two protein crystallography groups.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK045460-01
Application #
3246951
Study Section
Endocrinology Study Section (END)
Project Start
1992-09-30
Project End
1996-09-29
Budget Start
1992-09-30
Budget End
1993-09-29
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Gamble, Matthew J; Fisher, Robert P (2007) SET and PARP1 remove DEK from chromatin to permit access by the transcription machinery. Nat Struct Mol Biol 14:548-55
Larochelle, Stephane; Batliner, Jasmin; Gamble, Matthew J et al. (2006) Dichotomous but stringent substrate selection by the dual-function Cdk7 complex revealed by chemical genetics. Nat Struct Mol Biol 13:55-62
Fisher, Robert P (2005) Secrets of a double agent: CDK7 in cell-cycle control and transcription. J Cell Sci 118:5171-80
Gamble, Matthew J; Erdjument-Bromage, Hediye; Tempst, Paul et al. (2005) The histone chaperone TAF-I/SET/INHAT is required for transcription in vitro of chromatin templates. Mol Cell Biol 25:797-807
Barletta, Frank; Freedman, Leonard P; Christakos, Sylvia (2002) Enhancement of VDR-mediated transcription by phosphorylation: correlation with increased interaction between the VDR and DRIP205, a subunit of the VDR-interacting protein coactivator complex. Mol Endocrinol 16:301-14
Staeva-Vieira, Teodora P; Freedman, Leonard P (2002) 1,25-dihydroxyvitamin D3 inhibits IFN-gamma and IL-4 levels during in vitro polarization of primary murine CD4+ T cells. J Immunol 168:1181-9
Burakov, Darya; Crofts, Linda A; Chang, Chao-Pei Betty et al. (2002) Reciprocal recruitment of DRIP/mediator and p160 coactivator complexes in vivo by estrogen receptor. J Biol Chem 277:14359-62
Maeda, Yutaka; Rachez, Christophe; Hawel 3rd, Leo et al. (2002) Polyamines modulate the interaction between nuclear receptors and vitamin D receptor-interacting protein 205. Mol Endocrinol 16:1502-10
Yang, W; Rachez, C; Freedman, L P (2000) Discrete roles for peroxisome proliferator-activated receptor gamma and retinoid X receptor in recruiting nuclear receptor coactivators. Mol Cell Biol 20:8008-17
Burakov, D; Wong, C W; Rachez, C et al. (2000) Functional interactions between the estrogen receptor and DRIP205, a subunit of the heteromeric DRIP coactivator complex. J Biol Chem 275:20928-34

Showing the most recent 10 out of 27 publications